Loading…
11 verbatim requirements from 10-Key-Components-of-Drug-Court.pdf.
Fourth Judicial Circuit (Duval, Clay, Nassau). Procedural information only; not legal advice.
Verbatim from https://www.jud4.org/getContentAsset/87985595-ddd7-4021-8676-a713c2c684aa/135b97c9-84fa-4e82-b956-0fbccec4aa1f/10-Key-Components-of-Drug-Court.pdf?language=en, harvested 2026-07-25; whitespace normalised only. • Points of view in this document are those of the authors and do not necessarily represent the official positions or policies of the U.S. • Mechanisms for sharing decisionmaking and resolving conflicts among drug court team members, such as multidisciplinary committees, are established to ensure professional integrity. 2 All communication about an individual’s participation in treatment must be in compliance with the provisions of 42 CFR, Part 2 (the federal regulations governing confidentiality of alcohol and drug abuse patient records), and with similar State and local regulations. 2 -- 6 of 32 -- • To facilitate an individual’s progress in treatment, the prosecutor and defense counsel must shed their traditional adversarial courtroom relationship and work together as a team. • AOD is to be effective, it must also call on the resources of primary health and mental health care and make use of social and other support services.3 • In addition, treatment services must be relevant to the ethnicity, gender, age, and other characteristics of the participants. • For the many communities that do not have adequate treatment resources, drug courts can provide leadership to increase treatment options and enrich the availability of support services. • Drug courts must reward cooperation as well as respond to noncompliance. • A drug court judge must be prepared to encourage appropriate behavior and to discourage and penalize inappropriate behavior. • Evaluation studies are useful to everyone, including funding agencies and policymakers who may not be involved in the daily operations of the program. • Automated manual information systems must adhere to written guidelines that protect against unauthorized disclosure of sensitive personal information about individuals. • AOD treatment or mental health treatment history; medical needs (including detoxification); and nature and severity of AOD problems. ❑ Number and characteristics of participants (e.g., duration of treatment involvement, reason for discharge from the program). ❑ Number of active cases. ❑ Patterns of drug use as measured by drug test results. ❑ Aggregate attendance data and general treatment progress measurements. ❑ Number and characteristics of persons who graduate or complete treatment successfully. ❑ Number and characteristics of persons who do not graduate or complete the program. ❑ Number of participants who fail to appear at drug court hearings and number of bench warrants issued for participants. ❑ Rearrests during involvement in the drug court program and type of arrest(s). ❑ Number, length, and reasons for incarcerations during and subsequent to involvement in the drug court program.
Points of view in this document are those of the authors and do not necessarily represent the official positions or policies of the U.S.
Reviewer note: Document sha256: f6205cf7d8b98660718c792821ee6e230f37acd533f37fe17b9b82b355f98097. Extracted from the document's own text layer.
Judge Bell caps motions and responses at 5 pages for UMC hearings and 12 pages for special-set hearings.
Judge Alijewicz requires every motion for attorney's fees and/or costs to attach a document detailing time records — no records, no fee award.
Judge Corlew bars informal contact: every communication with the Court must be in writing, filed with the Clerk, with copies furnished to all parties — and no calls to the JA to schedule or cancel UMC.